ODDB.org: Open Drug Database | Drugs

Pemetrexed Sandoz conc. 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung - 5

Swissmedic Key	66501002	Registration Holder	Sandoz Pharmaceuticals AG
Name	Pemetrexed Sandoz conc. 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	17.07.2018
		Introduction of Sequence	17.07.2018
ATC-Classification	Pemetrexed (L01BA04)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size	5
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680665010021	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

pemetrexedum 100.0 mg ut pemetrexedum dinatricum hemipentahydricum, natrii thiosulfas, propylenglycolum 200.0 mg, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 11.34 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Pemetrexed	100mg / 4ml

BAG: Active Agent	Dose
Pemetrexed	100 mg

Inactive agents	Dose
Acidum Hydrochloridum
Sodium Hydroxide
Sodium Thiosulfate
Propylenglycol	200mg / 4ml

Source

Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH